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Arachidonic acid (AA) is generated in the anterior pituitary gland upon stimulation by the ACTH
secretagogue,CRH.Usingthepatchclamptechnique,weexaminedtheactionofAAontheexcitability
of single pituitary corticotropes obtained froma transgenicmouse strain that expresses the enhanced
green fluorescent protein driven by the proopiomelanocortin promoter. CRH evoked depolarization,
but AA caused hyperpolarization. Under voltage clamp condition, AA caused a rapid inhibition of the
delayed rectifierK currentand then increasedabackgroundK current. InhibitionofAAmetabolism
didnotprevent theactivationof theK currentbyAA, suggestingadirect actionofAA. The sensitivity
of theAA-activated K current to fluoxetine, chlorpromazine, extracellular acidification, diphenylbu-
tylpiperidine antipsychotics, and the membrane permeable cAMP analog [8-(4-chlorophenylthio)-
cAMP] suggest that the current ismediatedviaTWIK-relatedK channel (TREK)-1 channels.Activation
of the CRH receptors that are coupled to the adenylate cyclase pathway suppressed the activation of
TREK-1 current byAAand reversed theAA-mediatedhyperpolarization. Intracellular acidification (pH
7.0) increasedthebasalamplitudeofTREK-1currentandresulted inhyperpolarizaton.CRHsuppressed
thebasal TREK-1 current in cellswith intracellular acidificationand causeddepolarization.Our finding
indicates that TREK-1 channels are important in setting the resting potential in corticotropes. The
opposing actions of CRH and AA on the excitability of corticotropes raise the possibility that AAmay
actasanegativefeedbackregulatortoreducethestimulatoryactionofCRHandthuspreventexcessive
ACTH release during chronic stress.
The endocrine response to stress is primarily controlledby the hypothalamic-pituitary-adrenal axis. During
stress, neurons in the paraventricular nucleus of the hy-
pothalamus release CRH into the portal circulation. CRH
stimulates the release of the stress hormone, ACTH from
pituitary corticotropes. The CRH-stimulated ACTH se-
cretion is dependent on cytosolic [Ca2] ([Ca2]i) eleva-
tion (1). We have shown previously in rat corticotropes
that the stimulation of CRH receptors causes closure of a
backgroundK current, which in turn leads tomembrane
depolarizationandactivationof voltage-gatedCa2 chan-
nels (2). The depolarization-evoked rise in [Ca2]i in turn
triggered exocytosis in rat corticotropes (3). Thus, the re-
lease ofACTHduringCRHstimulation is regulatedby the
electrical excitability of the corticotropes. However, the
identity of the CRH-sensitive background K current in
corticotropes remains elusive.CRHalsoevokes the release
of arachidonic acid (AA) from rat pituitary cells (4, 5). The
role of AA in ACTH secretion is controversial. At high
concentrations (100 M), AA stimulated basal ACTH
release (4, 6), and inhibition of AA metabolism was re-
ported to either enhance or reduce the CRH-mediated
ACTH release (4–6). The complexity of the effects of AA
on ACTH secretion may be partially related to the diverse
Abbreviations: AA,Arachidonic acid; AVP, arginine vasopressin; AZF, adrenal zona fasciculata;
8CPT-cAMP, 8-(4-chlorophenylthio)-cAMP; DPBP, diphenylbutylpiperidine; eGFP, enhanced
green fluorescent protein; ETYA, eicosatetraynoic acid; pHext, pH in the extracellular solution;
pHint, intracellular pH; POMC, proopiomelanocortin; TASK, TWIK-related acid sensing K

channel;TEA, tetraethylammonium;TRAAK,TWIK-relatedarachidonicacidactivatedKchan-
nel; TREK, TWIK-related K channel; TWIK, tandem of pore domains in a weak rectifying K
channel.
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actions of AA on ion channels. For example, AA was
found to modulate multiple types of voltage-gated K
channels, including the inhibition of the A-type and the
delayed rectifier K channels (7). In addition, AA was
reported to inhibit some members of the tandem of pore
domains in a weak rectifying K channel (TWIK)-related
acid-sensing K channels (TASK) family but activated all
three members [TWIK-related K channel (TREK)-1,
TREK-2, and TWIK-related arachidonic acid activated
K channel (TRAAK)] of the TREK (TWIK-related K
channels) family (8). Both the TWIK-related acid-sensing
K channels and TREK families belong to the tandem-
pore class ofK (K2P) channels,whichare important in the
setting of the resting potential in many cell types (8). In
view of the importance of membrane excitability in the
stimulatory action of CRH in rat corticotropes (2), it is
possible thatAAmayaffect corticotropes via its actions on
ion channels and cellular excitability. In the current study,
we employed mouse corticotropes obtained from the pro-
opiomelanocortin (POMC)-enhanced green fluorescent
protein (eGFP) transgenic mice (9–11). Because the
POMC promoter sequence targets eGFP expression to all
cell types that normally express POMCgeneproducts (e.g.
ACTH, -lipotropin, -MSH, and -endorphin), the
ACTH containing pituitary corticotropes and MSH
containing intermediate lobemelanotropes in this transgenic
mouse model also express GFP fluorescence (12). We
found that AA caused hyperpolarization inGFP-labeled
mouse corticotropes via the activation of TREK-1 chan-
nels. Most importantly, CRH acting via the cAMP-de-
pendent pathway inhibited the same channel and caused
depolarization. Inhibition of TREK-1 channels at basal
condition by CRH or fluoxetine resulted in depolariza-
tion. In the presence of fluoxetine, the CRH-mediated
depolarization was attenuated. Overall, our findings
indicate that TREK-1 channels have major roles in the
setting of the resting potential in corticotropes, and the
activities of the TREK-1 channels are reciprocally reg-
ulated by CRH and AA. The generation of AA in the
corticotropes after CRH stimulation can cause hyper-
polarization, which in turn limits the depolarizing ac-
tions of CRH.This raises the possibility that AAmay act
as an intrinsic negative regulator of ACTH secretion
during chronic stress.
Materials and Methods
Cell culture
The generation of the POMC-eGFP transgenic mice was as
described previously (9). To identify mice that express POMC-
eGFP from the mixed litter, the pituitary gland was removed
from mice killed in accordance with standards of the Canadian
Council on Animal Care. Because the intermediate lobe of the
pituitary gland comprises mostly melanotropes that express
-MSH, a POMC gene product, the intermediate lobe of the
pituitary gland in the POMC-eGFPmouse exhibits intense green
fluorescence when viewed under a dissecting microscope. The
anterior lobes of the pituitary glands were dissected from these
mice and dissociated enzymatically as previously described (13).
Dissociated pituitary cellswere plated onpoly-lysine (0.1mg/ml;
Sigma-AldrichCanada,Oakville,Ontario, Canada) coated glass
coverslips and maintained in standard culture condition in
DMEM supplemented with 10% (vol/vol) horse serum, 50 U/ml
penicillinG, and50mg/ml streptomycin (all fromSigma) for 1–3
d. Individual corticotropes were identified from the heteroge-
neous pituitary cell population by their GFP fluorescence (ob-
served with an excitation filter at 400–440 nm and an emission
filter at 520–560 nm).
Reverse hemolytic plaque assay
The procedure for the reverse hemolytic plaque assay was
similar to that described previously (2, 14, 15). Briefly, dissoci-
ated mouse pituitary cells were suspended in DMEM supple-
mented with 0.1% (wt/vol) BSA. The pituitary cell suspension
was then mixed with one-third the volume of 12% (vol/vol)
sheep erythrocytes (Colorado Serum Co., Denver, CO) in 0.9%
(wt/vol) NaCl. The erythrocytes were previously conjugated
with Staphylococcus aureus-derivedproteinA (Sigma), using0.2
mg/ml CrCl3 as a catalyst. The combined cell suspension was
incubated with a mixture of 10 nM CRH and 100 nM arginine
vasopressin (AVP) and rabbit polyclonal antibodies to ratACTH
(1:20 dilution; gift from R. J. Kemppainen, Auburn University,
Auburn, AL) for 3 h at 37C. Plaques (zone of lysed erythrocytes)
were formed by a 30-min exposure to guinea pig complement at
1:50 dilution.
Electrophysiological recording
Membrane potential or currentwas recordedwith thewhole-
cell patch clamp technique with an EPC-9 patch clamp amplifier
(HEKA Electronics, Mahone Bay, Nova Scotia, Canada). The
standard bath solution contained (inmM): 150NaCl, 10HEPES,
8 glucose, 2.5 KCl, 2 CaCl2, and 1 MgCl2 (pH 7.4). For most
experiments, the whole-cell pipette solution contained (in mM):
120 K-aspartate, 20 HEPES, 20 KCl, 1 MgCl2, 10 EGTA, 2
Na2ATP, and 0.1 Na4GTP (pH 7.4). Because TREK-1 current
can be increased by intracellular acidification (16), we employed
a whole-pipette solution that was buffered to pH 7.0 in some
experiments. All experiments were performed at room temper-
ature (20–23 C). A 10 mV, junction potential was corrected
throughout. For the generation of IV plots, individual cell was
voltage clamped at 70 mV and then stepped to different po-
tentials (80 to 40 mV in 10-mV increment) for 200 msec. The
current amplitude at different potentials was averaged from the
last 40 msec of the voltage step.
Statistical analysis
Origin program 8 (OriginLab Corp., Northampton, MA)
was employed for plotting and statistical procedures. The
two-sample Student’s t test was used in comparisons of values
between twopopulationsof cells.AnydifferencewithP0.05was
considered statistically significant andwasmarkedwith an asterisk
in the figures. All values shown were means SEM.
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Results
CRH caused membrane depolarization in GFP-
fluorescent mouse corticotropes
To confirm that theGFP-fluorescent cells isolated from
the anterior pituitary gland are corticotropes, we exam-
ined whether individual GFP-fluorescent cells secrete
ACTHwhen challenged with CRH and AVP. Tomeasure
ACTHsecretion fromsingle cells,we employed the reverse
hemolytic plaque assay using a polyclonal antibody to rat
ACTH. Figure 1A shows that individual GFP-fluorescent
mouse pituitary cells formed plaques (a zone of lysed
erythrocytes), indicating that ACTH was released from
the GFP-fluorescent cells. In 49 GFP-fluorescent cells ex-
amined, approximately 73% of the cells formed plaques,
suggesting that upon stimulation, most of the GFP-fluo-
rescent cells can secrete sufficient amount of ACTH that is
detectablewith the reverse hemolytic plaque assay. For the
rest of this study, we identified individual corticotropes
from POMC-eGFP transgenic mice based on their GFP
fluorescence. Using the whole-cell patch technique, we
examined whether CRH affected the membrane poten-
tial. For the majority of the experiments described here
(except for figure 8, C and D), the whole-cell pipette
solution was buffered to pH 7.4. Figure 1B shows that
CRH evoked depolarization in a GFP-fluorescent
mouse corticotrope. To examine whether the
depolarization was accompanied by changes
in cell input resistance, we injected small cur-
rent pulses (5 pA) into the cell. In five cells
examined, CRH depolarized the cell mem-
brane potential from52 6 to31 5mV
(Vm of21mV) (Fig. 1C) and increased the
cell input resistance from 1.3  0.3 to 2.4 
0.8 G (Fig. 1D). This result suggests that
the CRH-mediated depolarization in mouse
corticotropes may involve the closure of cer-
tain background conductance.
AA caused hyperpolarization via the
activation of an outward current
In contrast to the depolarizing action of
CRH, AA caused membrane hyperpolariza-
tion. As shown in Fig. 2A, application of AA (5
M) resulted in strong hyperpolarization. The
membrane potentialwas restored to basal level
upon the removal of AA. Note that in the con-
tinuedpresenceofAA, themembranepotential
reached a plateau (e.g. see figure 8A). The rest-
ing potential of mouse corticotropes typically
ranged from 40 to 50 mV. In 53 cells ex-
amined, the resting potentialwas483mV.
Figure 2B shows the average hyperpolarization
caused by 5 or 10 M AA. For cells challenged with 5 M
AA, their mean resting potential before and after AA was
40  2 and 78  3 mV (n 	 21) (Fig. 2B). For cells
challenged with 10 M AA, their mean resting potential
was hyperpolarized from 45  2 to 82  3 mV (n 	
4) (Fig. 2B). To examine the ionic mechanisms underlying
the AA-mediated hyperpolarization, we voltage-clamped
individual corticotropes at 70 mV and applied voltage
steps (200 msec in duration) to different potentials
(10-mV increment) during the time course of the applica-
tion ofAA.An example of this experiment is shown in Fig.
3. In control condition (before AA application), outward
currents that resembled the delayed rectifier could be
evoked at potentials more than or equal to20 mV (Fig.
3Ai). Application of AA (10 M) resulted in a gradual
increase in the holding current at70mV(Fig. 3B).About
2 min after the beginning of AA perfusion, the amplitude
of the delayed rectifier-like current (activated at potentials
20mV) was reduced, and there was an acceleration in
the decay of this voltage-activated current (Fig. 3Aii). Sub-
sequently (5 min after the onset of AA perfusion), AA
completely suppressed the delayed rectifier-like current
and activated an outward current that exhibited little time
dependence during the voltage step (Fig. 3Aiii). The re-
moval of AA eliminated the time-independent outward
FIG. 1. GFP-fluorescent mouse corticotropes secreted ACTH and depolarized in
response to CRH stimulation. A, The plaque-forming mouse pituitary cells in the
reverse hemolytic plaque assay were GFP fluorescent. Brightfield (left panels) and
fluorescent images (right panels) of two mouse pituitary cells that formed plaques. B,
Application of CRH (20 nM) evoked depolarization in a GFP-fluorescent cell. The
downward deflections in membrane potential, Vm, were induced by the injection of
current pulses (5 pA) to monitor changes in cell input resistance. C, CRH caused
depolarization. The resting Vm (control) and Vm in the presence of CRH (20 nM)
averaged from five corticotropes. D, The CRH-mediated depolarization was
accompanied by an increase in cell input resistance. The average cell input resistance
(Rs) before (control) and in CRH (same cells as in C).
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current (Fig. 3B) but failed to reverse the effects of AA on
the delayed rectifier-like current (Fig. 3Aiv). As shown in
Fig. 3C, AA initially suppressed the outward current
evoked at potentials more than or equal to20 mV (Fig.
3Cii) but subsequently activated a time-invariant outward
current at all potentials examined (Fig. 3Ciii). The re-
moval of AA reversed the activation of the time-invariant
outward current but not the reduction in the amplitude or
the acceleration in the decay kinetic of the delayed recti-
fier-like current (Fig. 3Civ). Because a change in the cur-
rent level near the resting potential can strongly affect
cellular excitability, we examined the change in current
level by AA at40mV (near themean resting potential of
corticotropes) (Fig. 2B). In 53 cells examined, the mean
membrane current at 40 mV before the application of
AA (control condition) was1.5 0.7 pA, and this value
increased to 102.6 9.8 pA in the presence of 10 MAA.
For cells challenged with 5 M AA, the increase in mem-
brane current at 40 mV was approximately 3-fold
smaller (30 6 pA; n	 26), suggesting that the effect of
AA on current activation is concentration dependent. Be-
cause the current response was more robust in 10 MAA,
we employed 10 M AA in all subsequent experiments.
The AA-activated current did not require AA
metabolism and was carried primarily by K
Theresult inFig.3suggests that the initialeffectofAAwas
a suppression of the delayed rectifier. Consistent with this
notion, in the presence of tetraethylammonium (TEA)
(an inhibitor of the delayed rectifier), only the enhanc-
ing effect of AA on the time-invariant outward current
was observed (Fig. 4). As shown in Fig. 4A, application
of TEA eliminatedmost of the delayed rectifier-like cur-
rent evoked at potentials more than or equal to 20
mV. In the continued presence of TEA, AA activated an
outward current at potentials more than 80 mV (Fig.
4B), and this current exhibited little time dependence
during the individual voltage step (Fig. 4A). Because AA
is metabolized in cells into a variety of eicosanoid prod-
ucts, we tested whether the effect of AA on the outward
current requires AA metabolism. We examined whether
the actions of AA can be prevented by eicosatetraynoic
acid (ETYA), a nonmetabolizable analog of AA that is a
blocker of lipoxygenase, cycloxygenase, and P450 path-
ways for AAmetabolism (17). As shown in the example in
Fig. 4C, application of ETYA (30 M) partially reduced
the current evoked at potentials more than 0mV, suggest-
ing that ETYA partially mimicked the inhibitory action of
AA on the delayed rectifier. However, in the continued
presence of ETYA, AA (10 M) could still enhance the
time-invariant outward current at all potentials. In the
presence of extracellular ETYA (30 M), the mean in-
crease in outward current at40 mV by AA (10 M) was
81.2  29.4 pA (n 	 3). In separate experiments, we in-
cluded ETYA (30 M) in the whole-cell pipette solution.
Under this condition, exogenous AA (10 M) could still
activate an outward current, and the mean increase in
current at 40 mV was 104.7  35.0 pA (n 	 4). These
values are similar to the AA-mediated enhancement of
current described above in control cells (102.6 9.8 pA;
n 	 53). Thus, AA metabolism is not essential for the
activation of outward current by AA. To examine whether
the AA-activated current is a K current, we voltage-
clamped individual corticotropes at70mV in an extracel-
lular solution containing 9, 19, 36, or 87 mM [K]. Voltage
steps (200 msec in duration) were then applied to different
potentials (10-mV increment) before and after the applica-
tion of AA (10 M). Because AA inhibited the delayed rec-
tifier current, the difference between the current evoked in
AA and the control (before AA application) comprised pri-
marily the AA-activated current. Figure 5A shows examples
of IVplotof theAA-activatedcurrentwhencellswerebathed
in different extracellular [K]. Note that the reversal poten-
tial of theAA-activated current shifted towardmorepositive
potentialswith increasingextracellular [K].Figure5Bsum-
marizes the reversal potential of the AA-activated current
obtained from various cells in the presence of the four
different extracellular [K]. The slope of the linear regres-
sion is 45mV (cf. 57mV expected for K), suggesting that
the AA-mediated current is carried primarily by K.
FIG. 2. AA caused hyperpolarization in corticotropes. A,
Representative example of the changes in membrane potential (Vm) of
a corticotrope when exposed to AA (5 M). B, Mean hyperpolarization
evoked by 5 or 10 M AA. The resting Vm before (control) and in the
presence of AA from the same group of cells were shown.
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The AA-mediated current was due to activation of
TREK-1 channels
Because AAwas reported to activate the TREK family of
K channels (8), we examined the involvement of the TREK
and TRAAK channels using pharmacological blockers. We
first tested the antidepressant, fluoxetine, which was re-
ported to be a potent inhibitor of human TREK-1 channels
(18, 19). As shown in the example in Fig. 6A, application of
fluoxetine (50M) in the continued presence of AA (10M)
reduced the outward current over awide rangeof potentials.
Insixcellsexamined, themeanreductionoftheAA-mediated
current by fluoxetine (50M) at40mVwas827%(Fig.
6E). We found that the AA-mediated current could also be
reduced by the antipsychotic drug, chlorpromazine, which
was shown to inhibit both human TREK-1 and TREK-2
channels but not TRAAK channels (20). Figure 6B shows
that application of chlorpromazine (10M) in the continued
presence of AA suppressed the current at all potentials ex-
amined. On average, chlorpromazine (10 M) reduced the
AA-mediated current at40 mV by 57 7% (n	 6) (Fig.
6E). The sensitivity of the AA-mediated K current to flu-
oxetine and chlorpromazine suggests
that the AA response in corticotropes in-
volves primarilyTREK-1orTREK-2but
not TRAAK channels. Consistent with
this, Fig. 6C shows that ruthenium red
(10 M), which was reported to inhibit
approximately 80% of the TRAAK
channels (21), had only a minor effect
(33 12%; n	 8) on the AA-mediated
current in corticotropes (Fig. 6E). Extra-
cellular acidification was reported to in-
hibit TREK-1 channels but enhance
TREK-2 channels (22). To further distin-
guishbetween the involvementofTREK-1
andTREK-2 channels,we lowered thepH
in the extracellular solution (pHext) from
7.4 to6.4.Figure 6D shows that extracel-
lular acidification caused a partial inhi-
bition of the AA-mediated current. In
eight cells examined, extracellular acidi-
fication reduced the AA-mediated cur-
rent at 40 mV by 44  6% (Fig. 6E).
Thus, the pharmacological profile of the
AA-activatedKcurrent incorticotropes
resembles that of TREK-1 channels. The
diphenylbutylpiperidine (DPBP)antipsy-
chotics, such as penfluridol and pimoz-
ide, have been reported to be highly po-
tent inhibitors of the TREK-1 channels
that are basally expressed (i.e. in the ab-
senceAA) inbovineadrenalzonafascicu-
lata (AZF) cells (23,24). Figure6F shows
that penfluridol at 2 and 10 M suppressed the current ac-
tivatedby10MAAinmousecorticotropesby305%(n	
6) and884%(n	6), respectively.A similar responsewas
obtained with pimozide (Fig. 6F); pimozide at 2 and 10 M
reduced the current activated by 10 M AA by 45  10%
(n 	 5) and 86  1% (n 	 3), respectively. Interestingly,
when the concentration of AA was lowered to 2 M, pimo-
zide at 2 M reduced the AA-mediated current by 82 6%
(n	 3) (Fig. 6F). This raises the possibility that the potency
of DPBP in suppressing TREK-1 channels may be related to
the concentration of AA employed to activate the channels.
The AA-activated TREK current was negatively
regulated by cAMP and CRH
The TREK, but not TRAAK, channels are sensitive to
cAMP (16). Consistentwith the activation ofTREK-1 chan-
nels by AA, we found that the membrane permeable cAMP
analog,8-(4-chlorophenylthio)-cAMP(8CPT-cAMP),strongly
reduced the AA-mediated outward current in cortico-
tropes. Figure 7A shows that the increase in outward cur-
FIG. 3. Dual actions of AA on membrane current. A, Current traces evoked from voltage steps
(200 msec) to40,20, 0, and 20 mV from a holding potential of70 mV in control condition
(i), in the presence of 10 M AA (ii and iii), and after AA removal (iv). At approximately 2 min after
starting the perfusion of AA, there was a reduction and a change in the decay kinetics of the
delayed rectifier-like current evoked at potentials more than or equal to20 mV (ii). After
approximately 5 min of perfusion, AA increased an outward current that exhibited little time
dependence during the voltage step (iii). The increase in the time-invariant outward current (but
not the inhibition of the delayed rectifier-like current) was reversed upon the removal of AA (iv). B,
Changes in the holding current at70 mV during AA application. Same cell as in A. At the
different times indicated (i–iv), the cell was voltage stepped to different potentials (80 to 40 mV
in 10-mV increment). C, IV plots at different time course of AA application. The current at
different potentials was measured from the mean of the last 40 msec of the voltage step (same
cell as in A and B). Note that the delayed rectifier-like outward current evoked at potentials more
positive than20 mV was initially suppressed by AA (ii). Subsequently, AA enhanced the time-
invariant outward current (iii) at all potentials examined.
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rent at70 mV by AA (10 M) was essentially abolished
by the application of 8CPT-cAMP (500 M). As shown in
Fig. 7B, 8CPT-cAMPsuppressed theAA-activated current
at a wide range of potential. In seven cells examined,
8CPT-cAMP (500 M) reduced the AA-mediated current
at40 mV by 76 7%. Because CRH receptors are cou-
pled to adenylate cyclase, we examined whether the acti-
vation of CRH receptors also modulates the TREK cur-
rent. Figure 7C shows that the AA-mediated increase in
outward current at 70 mV was strongly suppressed by
CRH (20 nM). The IV plot in Fig. 7D shows that CRH
suppressed the AA-mediated current at a wide range of
potentials. On average, CRH (20 nM) suppressed the AA-
mediated current at40 mV by 76 7% (n	 7). Figure
8A shows that CRH also reversed the AA-mediated hyper-
polarization. In sixteen cells examined, theAA-mediatedhy-
perpolarization was 38  3 mV, and the application of
CRH (in the presence of AA) depolarized the cells by 26 3
mV (n 	 12) (Fig. 8B). Thus, in the presence of AA, the
CRH-mediated depolarization could only partially restore
the potential to the basal values (before AA). Application of
the TREK-1 channel inhibitor, fluoxetine (50 M), to corti-
cotropes under basal condition (without
AA) depolarized the cells by 23 3 mV
(n 	 23) (Fig. 8B), similar to the depo-
larization evoked by CRH (21 mV)
(Fig. 1C). In the presence of fluoxetine,
theCRH-evokeddepolarization (Vm	
11 2mV; n	 10) (Fig. 8B) was signif-
icantly smaller (P 	 0.04) than that
evoked by CRH in control cells (Vm	
215mV) (Fig. 1C), suggesting that the
CRH response was attenuated by the in-
hibition of TREK-1 channels.
In all the experiments described
above, the intracellular pH (pHint) was
buffered to pH 7.4 with the whole-cell
pipette solution. Because intracellular
acidification was known to activate
TREK-1 channels (16), we examined
whether lowering the pHint to 7.0 af-
fected thebasal activity ofTREK-1 chan-
nels in corticotropes. Figure 8C shows
that in cells recorded with a whole-cell
pipette solution of pH7.0, the amplitude
of the background TREK-1 current at
40 mV was 24  4 pA (n 	 21). This
value is comparable with the current re-
corded from cells with pHint of 7.4when
stimulated by 5 MAA (30 6 pA; n	
26) but much larger than the basal
TREK-1current atpHint 7.4 (1.50.7
pA; n	 53). As shown in Fig. 8C, appli-
cationofCRH(20nM)or fluoxetine (50M)essentiallyelim-
inated the background TREK-1 current in cells with intra-
cellular acidification. The increase in basal TREK-1 current
with intracellular acidification was accompanied by hyper-
polarization. Figure 8D shows that the mean resting poten-
tial incorticotropeswithpHint7.0(822mV;n	22)was
more negative (Vm of 34 5mV) than that recorded from
cellswithpHint of7.4 (483mV;n	53)but comparable
withcorticotropes (withpHint 7.4) thatwere stimulatedwith
AA (Fig. 2). Application of CRH (20 nM) or fluoxetine (50
M) caused a similar depolarization in these cells (Vm of
354mVforCRHand364mVfor fluoxetine) (Fig.8D).
Thus, the activity of TREK-1 channel is responsible for set-
ting the resting potential of corticotropes.
Discussion
AA inhibited the delayed rectifier but increased
the TREK-1 current
Our results show that in GFP-labeled mouse cortico-
tropes, exogenous application ofAA caused an initial sup-
FIG. 4. The AA-mediated enhancement of the time-invariant outward current was not affected
by TEA or ETYA. A, After the inhibition of the delayed rectifier by TEA, AA increased the time-
invariant outward current. Current traces evoked from voltage steps (200 msec) to40,20, 0,
and 20 mV from a holding potential of70 mV in control, in TEA (10 mM), and in the presence of
10 M AA 10 mM TEA. Note that TEA alone eliminated most of the delayed rectifier evoked at
positive potentials. In the presence of TEA, AA increased an outward current, which exhibited little
time dependence. B, IV plots of the same cell (as in A) in control, in TEA, or in TEA 10 M AA.
Note that in control condition, most of the delayed rectifier evoked at potentials more than or
equal to20 mV was suppressed by TEA. In the presence of TEA, AA enhanced the time-
invariant outward current at all potentials examined. C, The AA-mediated enhancement of the
time-invariant outward current did not require AA metabolism. ETYA, an inhibitor of AA
metabolism, caused a small reduction in the delayed rectifier but could not prevent the enhancing
effect of AA on the time-invariant outward current. IV plots of a cell in control, in ETYA (30 M),
and in ETYA 10 M AA.
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pression and acceleration in the current decay of the de-
layed rectifier (Fig. 3A). Similar actions of AA on the
delayed rectifier have been described in other cell types,
including the rat pulmonary arterial myocytes (25) and
bovine AZF cells (26). The AA-mediated inhibition of the
delayed rectifier was shown to cause depolarization in
pulmonary arterial myocytes (25). However, therewas no
activationof the delayed rectifier near the resting potential
of corticotropes. Instead, the dominant effect of AA in
corticotropes at the resting potential was the activation of
a background current. The shift in the reversal potential of
the AA-activated background current with changes in ex-
tracellular [K] (Fig. 5)was similar to that predictedby the
Nernst potential of K, indicating that the AA-activated
current was primarily carried by K. At 40 mV, the
mean increase in membrane current was approximately
100 pA. Because themean input resistance of corticotrope
is approximately 1.3 G (Fig. 1C), the large increase in
background K current by AA near the resting potential
resulted in a strong hyperpolarization (Fig. 2B).
Several lines of evidence indicate that the AA-activated
current in corticotropes is due to an increase in the activ-
ities of TREK-1 channels. First, the AA-mediated increase
in current did not require AA metabolism. Similar to that
described in bovine AZF cells (26), inhibition of AA me-
tabolism by ETYA failed to block the AA-mediated acti-
vation of the TREK-1 current in corticotropes (Fig. 4C).
Second, theAA-activated currentwas strongly suppressed
by pharmacological blockers of TREK channels but not
that of TRAAK channels.We found that the AA-activated
K current (at 40 mV) in corticotropes was reduced
approximately 80% and approximately 60%, respec-
tively, by fluoxetine (50 M) and chlorpromazine (10 M)
(Fig. 6E). These values closely resembled the reported val-
ues of inhibitionof humanTREK-1 channels by fluoxetine
(19) and human TREK-1 and TREK-2 channels by chol-
orpromazine (20). Our results ruled out the involvement
of TRAAK channels, because TRAAK channels are insen-
sitive to chlorpromazine (20). Furthermore, ruthenium
FIG. 5. The AA-mediated current was carried primarily by K. A, IV
plots of the AA-mediated current (difference between the current
evoked before and in the presence of 10 M AA) when cells were
bathed in different [K] ([K]o). B, Plot of the reversal potential (Eo) of
the AA-mediated current vs. extracellular [K]. The slope of the linear
regression was 45 mV. Each data point was the average of the reversal
potential obtained from six or 12 cells.
FIG. 6. The AA-activated current involves TREK-1 channels. A,
Application of the TREK-1 channel inhibitor, fluoxetine (50 M),
strongly suppressed the AA-mediated current at a wide range of
potentials. B, The AA-mediated current was also reduced by
chlorpromazine (10 M), an inhibitor of TREK-1 and TREK-2 channels.
C, Application of ruthenium red (10 M), an inhibitor of TRAAK
channels, had only minor inhibitory effect on the current. D, External
acidification (pHext 6.4) caused a partial inhibition of the current. A–D,
Representative IV plots from four different cells when exposed to 10
M AA and subsequently to the various inhibitors (in the continued
presence of AA). E, Summary of the average reduction of AA-mediated
current at 40 mV by fluoxetine (n 	 6), chlorpromazine (n 	 6),
ruthenium red (n 	 8), and pHext 6.4 (n 	 8). F, The effect of
penfluridol and pimozide (2 or 10 M) on the amplitude of AA-
mediated current at 40 mV. Values in each group were averaged
from three to six cells.
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red, a potent inhibitor of TRAAK channels (21), had only
aminor effect on theAA-activated current in corticotropes
(e.g. Fig. 6C). The AA-activated current was also sensitive
to DPBP; the current activated by 10 M AA was largely
inhibited by penfluridol or pimozide at
10 M (Fig. 6F). However, penfluridol
and pimozide were reported to inhibit
thebasalTREK-1 current (withoutAA)
in bovine AZF cells with IC50 values of
0.19 and 0.35 M, respectively (23).
This discrepancy may be related to the
high concentration of AA (10 M) used
to activate the TREK-1 channels in cor-
ticotropes.As shown inFig. 6F, a 5-fold
lower concentration of pimozide (2
M) was able to largely suppress the
current activated by 2 M AA. Third,
consistent with the activation of TREK
channels by intracellular acidification
(16), the lowering of pHint (from 7.4 to
7.0) dramatically increased the ampli-
tude of the basal current in cortico-
tropes. Fourth, the TREK, but not
TRAAK, channels are known tobeneg-
atively regulated by cAMP-dependent
signaling pathways, including protein
kinase A (27) and the cAMP-activated
guanine nucleotide exchange factors-
mediated pathway (28). Consistent with this, the cell per-
meable cAMP analog, 8CPT-cAMP (0.5 mM), strongly
suppressed the AA-activated K current in corticotropes
(e.g. Fig. 7B). Fifth, among the members of the
TREK family, only theTREK-1 channel exhib-
its a strong outward rectification due to its sen-
sitivity to extracellular divalent ions (16). Con-
sistent with the involvement of TREK-1
channels, the AA-mediated current in cortico-
tropes in the normal bath solution (containing
Ca2 and Mg2) exhibited outward rectifica-
tion (Fig. 4B). In corticotropes, the AA-acti-
vated current during each voltage step (e.g. at
20 mV) was essentially a square wave that ex-
hibited little time dependence (Fig. 3Aiii). Sim-
ilarly, the AA-activated TREK-1 current in bo-
vine AZF did not exhibit any time dependence
at 20 mV (26). In contrast, in cells with ex-
pressed human (19) or mouse TREK-1 chan-
nels (29), the TREK-1 current evoked at posi-
tive test potentials (0 mV) comprised an
instantaneous and a sustained component. It is
not clear whether this discrepancy is due to the
difference between native and expressed
TREK-1 channels. Lastly, extracellular acidi-
fication (pH 6.4) reduced the AA-activated K
current in corticotropes (Fig. 6E).Extracellular
acidification was reported to have inhibitory
FIG. 7. The AA-mediated current was negatively regulated by cAMP and CRH. A, The cell
permeable cAMP analog, 8CPT-cAMP (0.5 mM), strongly reduced the AA (10 M)-mediated
increase in outward current. The cell was voltage clamped at 70 mV. B, IV plots of the
current in AA and in AA  8CPT-cAMP. Same cell as in A. C, The AA (10 M)-mediated
increase in outward current was strongly suppressed by CRH (20 nM). The cell was voltage
clamped at 70 mV. D, IV plots of the current in the presence of AA and in AA  CRH. Same
cell as in C.
FIG. 8. Effects of CRH and intracellular acidification on membrane potentials. A,
The AA (10 M)-mediated hyperpolarization was reversed by CRH (20 nM). B,
Summary of the effects of AA (10 M), CRH (20 nM; in the presence of AA),
fluoxetine (50 M; in the absence of AA), and CRH (20 nM; in the presence of
fluoxetine) on membrane potentials. Values averaged from 10 to 23 cells (pHint 7.4)
for each treatment. C, Intracellular acidification (pHint 7.0) increased the basal
current at 40 mV (n 	 22), and this current could be inhibited by CRH (20 nM; n 	
9) or fluoxetine (50 M; n 	 5). D, Hyperpolarization induced by intracellular
acidification and its reversal by CRH or fluoxetine. Same cells as in C.
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action on human TREK-1 channels but enhancing actions
on TREK-2 channels (22). Our observation that approx-
imately 48% of the AA-activated current was inhibited
with pHext 6.4 was similar to that reported for murine
TREK-1 channels (22).
The TREK-1 channels set the resting potential and
were targets of CRH
Our previous study showed that CRH evoked depolar-
izationviaa cAMP-dependent closureof abackgroundK
conductance in rat corticotropes, but the identity of the
CRH-sensitive background K current remains elusive
(2).Here,we showthatCRHexerteda similar effecton the
membrane potential of GFP-labeled mouse corticotropes.
The CRH evoked membrane potential depolarization
(Fig. 1C) was accompanied by an increase in cell input
resistance (Fig. 1D), reflecting the closure of a background
conductance. We also found that application of the
TREK-1 channel inhibitor, fluoxetine, to mouse cortico-
tropes caused a similar depolarization (Fig. 8B). Although
fluoxetinewas also reported to inhibit the delayed rectifier
(30), there was no significant activation of the delayed
rectifier in corticotropes at potentials less than 20 mV
(Figs. 3 and 4). Thus, the fluoxetine-evoked depolariza-
tion in corticotropes is primarily due to the inhibition of
basal activity of TREK-1 channels. This finding suggests
that the resting potential of corticotropes is primarily de-
termined by the basal activity of TREK-1 channels. Con-
sistent with this, an increase in TREK-1 current by intracel-
lular acidification resulted in a stronghyperpolarization that
could be reversed by fluoxetine (Fig. 8D). The activities of
TREK-1 channels are strongly regulated by phosphoryla-
tion, and some TREK-1 channels are phosphorylated under
basal condition (16). Thismay contribute to the variability
of resting potential among corticotropes (ranging from
40 to 50 mV).
Our results also indicate that the CRH-sensitive
background K current is the TREK-1 current. As
shown in Fig. 8C, the basal TREK-1 current induced by
intracellular acidification was largely abolished by
CRH, resulting in a strong depolarization (Fig. 8D).
CRH also suppressed the TREK-1 current activated by
AA and reversed the AA-mediated hyperpolarization
(Figs. 7C and 8A). In the presence of fluoxetine, CRH
evoked only a small depolarization (11 mV) (Fig. 8B).
Fluoxetine inhibited only approximately 80% of the
TREK-1 current (Fig. 6E); thus, it is possible that the small
depolarization was due to a suppression of the remain-
ing TREK-1 current byCRH. Because theCRH receptor
is coupled to adenylate cyclase, the inhibitory action of
CRH is likely to bemediated via the elevation of cellular
cAMP (Fig. 7, A and B).
Potential role of AA as a negative feedback
regulator in ACTH release
Upon stimulation with CRH or AVP, AA is generated in
thepituitarygland(4,5).BecausebothCRHandAVPtrigger
[Ca2]i rise incorticotropes (2,15), it is likely that the [Ca
2]i
elevation activates the Ca2-dependent cytosolic form of
phospholipaseA2,which in turncleaves themembranephos-
pholipids to generate AA. The concentration of AA near the
corticotropesduringCRHstimulation isunclear,but inmost
tissues, theconcentrationofAAisestimated tobeat2–10M
(7).Note thatAA can activate TREK-1 channels from either
side of the plasmamembrane (16). It is conceivable thatwith
a prolonged CRH stimulation (e.g. during a chronic stress),
the concentration of AA near the plasma membrane (inside
oroutside)of a corticotrope could reach severalmicromolar.
In our experiments, 5 or 10MAAwas able to evoke strong
hyperpolarization (Fig. 2B). There was a 3-fold increase in
the amplitude of the TREK-1 current (at40 mV) in corti-
cotropes when the concentration of AAwas increased from
5to10M.Asimilar increase inTREK-1currentby the same
concentrationsofAAhadbeen reported inbovineAZF (26).
Therefore, it is likely that during a prolonged CRH stimu-
lation, the concentration of AA near the plasma membrane
of corticotropes could cause activation of the TREK-1 cur-
rent and hyperpolarization. This will in turn limit the depo-
larization evoked by CRH and thus reduce voltage-gated
Ca2 channels activation andACTHrelease. Interestingly, a
previous study has shown that AA at high concentration
(100M) increased basal ACTHrelease but had no effect on
theCRH-stimulatedACTHsecretion fromrat pituitary cells
(4).We found thatwhen corticotropeswere exposed to high
concentrationsofAA(e.g.30M), thepatchclamprecording
became unstable (possibly due to changes in membrane flu-
idity), and there was an increase in the leakage of extracel-
lular Ca2 into the cell (Lee, A. K. and A. Tse, unpublished
observations). Thus, it is possible that with very high con-
centrationsofAA,the increase inextracellularCa2 leakinto
corticotropes in turn triggersACTHrelease. Such effectmay
offset the inhibitoryactionofAAontheelectrical excitability
of the corticotropes. Overall, our result raises the possibility
thatAAatphysiological concentrations (5 to10M)mayact
as a negative regulator of ACTH release. We suggest that
other than the negative feedback action of glucocorticoids,
the activation of TREK-1 channels in corticotropes by AA
may provide an additional protective mechanism to prevent
excessive ACTH release during chronic stress.
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